Stem cell growth factor shows promise as Alzheimer's treatment

07/2/2009 | New Kerala (India)

A U.S. study on Alzheimer's disease mice models found that injections of the granulocyte-colony stimulating factor -- a human growth factor used to trigger blood stem cell production in the bone marrow -- reduced the levels of beta amyloid protein that is considered a hallmark of the disease, as well as increased neuron production and promoted nerve-cell connections. The results indicate that the growth factor shows promise as a treatment "that may actually reverse disease, not just alleviate symptoms like currently available drugs," the lead author said.

View Full Article in:

New Kerala (India)

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Senior Counsel – Regulatory Affairs
RAI Services Company
Winston-Salem, NC
Senior Counsel Commercial
RAI Services Company
Winston Salem, NC
Diagnostic Technician
Roche
Marlborough, MA
Test Technician
Roche
Marlborough, MA
Compliance and Ethics Director
Sysmex America, Inc.
Lincolnshire, IL